Home/Pipeline/AI-Personalized Chronic Disease Management Platform

AI-Personalized Chronic Disease Management Platform

Chronic Diseases (e.g., Diabetes, Hypertension, COPD)

Development/ValidationActive

Key Facts

Indication
Chronic Diseases (e.g., Diabetes, Hypertension, COPD)
Phase
Development/Validation
Status
Active
Company

About Samay

Samay is a private, early-stage digital health company building an AI/ML platform to enable personalized chronic disease management. Operating in the high-growth digital therapeutics and remote patient monitoring space, the company is likely pre-revenue and focused on platform development and validation. Its success will hinge on demonstrating clinical efficacy, securing regulatory pathways, and achieving integration within existing healthcare systems against established competitors.

View full company profile